CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Open-market buy Director bought 75,000 shares at an average $0.31 ($23,135)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Open-market buy President and CEO bought 5,000 shares at $0.35 ($1,750)
- 4 Open-market buy Director bought 50,000 shares at $0.38 ($18,750)
- 4 Open-market buy President and CEO bought 5,000 shares at $0.38 ($1,900)
- 4 Open-market buy General Counsel & VP of BD bought 18,000 shares at $0.39 ($7,056)
- 4 Open-market buy President and CEO bought 10,000 shares at an average $0.40 ($4,000)
- 4 Open-market buy Director bought 48,600 shares at $0.39 ($19,119)
- 4 Open-market buy Exec VP and Chief MO bought 6,000 shares at $0.39 ($2,323)
- 4 Open-market buy President and CEO bought 10,000 shares at an average $0.39 ($3,949)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 51,400 shares at $0.39 ($20,200)
- 4 Open-market buy VP & Chief Financial Officer bought 25,000 shares at $0.39 ($9,750)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 37 of 74 · 1,465 filings